ODANACATIB
UNII N673F6W2VH

Substance Identification & Data

This profile provides standardized clinical and technical data for Odanacatib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N673F6W2VH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 603139-19-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

N673F6W2VH

CAS Registry Number

603139-19-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ODANACATIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C25H27F4N3O3S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

FWIVDMJALNEADT-SFTDATJTSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C66981

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

10152654

Unique identification number in the NCBI database of chemical substances.

INN ID

8962

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

TT-63

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1CC1(C#N)NC(=O)[C@@H](N[C@@H](c2ccc(-c3ccc(cc3)S(C)(=O)=O)cc2)C(F)(F)F)CC(C)(C)F

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Odanacatib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.